Evidence map›Paper›PMID 41522806›Full record

ArticleOncology letters2026

Metastatic urothelial carcinoma of the urethra and glans penis with reported implantation via the urine: A case report.

Piotr Kalinowski, Paweł Nalej, Beata Grochulska-Nalazek, Tomasz Kalinowski, Tomasz Demkow, Olga Kuczkiewicz-Siemion, Roman Romaniuk

Abstract readCase Reports
In one paragraph

Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Piotr KalinowskiDepartment of Urogenital Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Paweł NalejDepartment of Urogenital Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Beata Grochulska-NalazekDepartment of Urogenital Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Tomasz KalinowskiDepartment of Urogenital Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Tomasz DemkowDepartment of Urogenital Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Olga Kuczkiewicz-SiemionDepartment of Pathology and Laboratory Diagnostics, Maria Skłodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Roman RomaniukDepartment of Pathology and Laboratory Diagnostics, Maria Skłodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urothelial carcinoma accounts for the vast majority of diagnosed bladder cancer cases. Urothelial carcinoma is prone to recurrence and metastasis despite complete resection of the lesions. The present case report describes a patient who underwent cystoprostatectomy due to a diagnosis of recurrent bladder cancer, with a penile lesion found several years after surgery. A partial penectomy was performed and the subsequent histopathology result showed urothelial carcinoma of the urethra and the epithelium of the glans and foreskin nested by micturition. The present case is an extremely rare incidence of the spread of cancer through the urine. To date, only a few such cases have been reported in the literature.

Indexed as

cutaneous and glans penis implantationmetastasisurothelial carcinoma

Identifiers

PMID41522806
PMCPMC12784185

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.